Palantir's Army-contract win sends stock surging
By Emily Bary
One bear is still cautious in the wake of a new Army award that could help reaccelerate U.S. government revenue
Palantir Technologies Inc. won a new Army contract, and that was giving its stock a big lift in Wednesday's premarket action.
Shares of Palantir (PLTR) were up more than 7% in early trading after the company said it won a U.S. Army award for development of the military branch's "next-generation deep-sensing capability," which will be powered by artificial intelligence.
The agreement, valued at $178.4 million, is for the Army's Tactical Intelligence Targeting Access Node (Titan) ground station system and covers 10 prototypes.
William Blair analyst Louie DiPalma suspected a day earlier that Palantir had won the contract, and according to his tracker, the deal "would be Palantir's fourth-largest contract by annual revenue run-rate."
While Palantir's U.S. commercial business has seen explosive growth lately thanks in part to uptake of the company's Artificial Intelligence Platform, the U.S. government business has been more sluggish.
"In our view, the Titan and Maven contracts will cause Palantir's U.S. government revenue to accelerate from its fourth-quarter 5% rate, which was the lowest mark since Palantir went public," DiPalma wrote. Maven refers to a defense contract.
Still, DiPalma remains bearish on Palantir shares, writing that Palantir's forecast for 2024 revenue trails where the consensus sell-side projection had been in January 2023, back when Palantir's stock was trading between $6 and $8.
"Ultimately, AI has not made a profound impact on Palantir's consolidated revenue trajectory," he wrote. "Even when adding this $89 million per year Titan contract to 2024 revenue, the total is still below analyst projections when the stock was trading 67% lower, despite robust demand environments on both the commercial and defense sides of the business."
DiPalma rates the stock at underperform.
-Emily Bary
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
03-06-24 0805ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track